Z. H. YANG, Z. R. YANG
Copyright © 2013 SciRes. ENG
mean differential expressions. It is this linear structure
that shapes the observed differential expressions from
multiple data sets in a multivariate model. The iSOM
approach can also be used in cross-omics and cross-spe-
cies studies.
REFERENCES
[1] T. Kohonen, “Self-Organizing Maps,” Springer, Berlin,
2001. http://dx.doi.org/10.1007/978-3-642-56927-2
[2] J. Yao, Q. Zhao, Y. Yua n, L. Zhang, X. Liu, W. K. Yung
and J. N. Wei nstein, “Identification of Common Prognos-
tic Gene Expression Signatures with Biological Meanings
From Microarray Gene Expression Datasets,” PLoS One,
Vol. 7, 2012, Article ID: e45894.
http://dx.doi.org/10.1371/journal.pone.0045894
[3] Y. Park, E. S. Park, S. B. Kim, S. C. Kim, B. H. Sohn, I.
S. Chu, W. Jeong, G. B. Mills, L. A. Byers and J. S. Lee,
“Development and Validation of a Prognostic Gene-Ex-
pression Signature for Lung Adenocarcinoma,” PLoS One,
Vol. 7, 2012, Article ID: e44225.
http://dx.doi.org/10.1371/journal.pone.0044225
[4] A. Zaravinos, G. I. Lambrou, D. Volanis, D. Delakas and
D. A. Spandidos, “Spotlight on Differentially Expressed
Genes in Urinary Bladder Cancer,” PLoS One, No. 6,
2011, Article ID: e18255.
http://dx.doi.org/10.1371/journal.pone.0018255
[5] M. LaBonte, P. M Wilson, W. Fazzone, S. Groshen, H. J.
Lenz and R. D. Ladner, “DNA Microarray Profiling of
Genes Differentially Regulated by the Histone Deacety-
lase Inhibitors Vorinostat and LBH589 in Colon Cancer
Cell Lines,” BMC Med Genomics, Vol. 2, 2009, p. 67.
http://dx.doi.org/10.1186/1755-8794-2-67
[6] M. Howlett, A. S. Giraud, H. Lescesen, C. B. Jackson, A.
Kalantzis, I. R. Van Drie l, L. Robb, M. Van der Hoek, M.
Ernst, T. Minamoto, A. Boussioutas, H. Oshima, M.
Oshima and L. M. Judd, “The Interleukin-6 Family Cyt o-
kine Interleukin-11 Regulates Homeostatic Epithelial Cell
Turnover and Promotes Gastric Tumor Development,”
Gastroenterology, Vol. 136, 2009, pp. 967-977.
http://dx.doi.org/10.1053/j.gastro.2008.12.003
[7] A. Alaiya, M. Al-Mohanna, M. Aslam, Z. Shinwari, L.
Al-Mansouri, M. Al-Rodayan, M. Al-Eid, I. Ahmad , K.
Hanash, A. Tulbah, A. Mahfooz and C. Adra, “Proteo-
mics-Based Signature for Human Benign Prostate Hyper-
plasia and Prostate Adenocarcinoma,” International
Journal of Oncology, Vol. 38, 2011, pp. 1047-1057.
http://dx.doi.org/10.3892/ijo.2011.937
[8] L. Cheng, W. Lu, B. Kulkarni, T. Pejovic, X. Yan, J. H.
Chiang, L. Hood, K. Odunsi and B. Lin, “Analysis of
Chemotherapy Response Programs in Ovarian Cancers by
the Next-Generation Sequencing Technologies,” Gyne-
cologic Oncology, Vol. 117, 2010, pp. 159-169.
http://dx.doi.org/10.1016/j.ygyno.2010.01.041
[9] A. Planche, M. Bacac, P. Provero, C. Fusco, M. Deloren-
zi, J. C Stehle and I. Stamenkovic, “Identification of
Prognostic Molecular Features in the Reactive Stroma of
Human Breast and Prostate Cancer,” PLoS One, Vol. 6,
2011, Article ID: e18640.
http://dx.doi.org/10.1371/journal.pone.0018640
[10] A. Collura, L. Marisa, D. Trojan, O. Buhard, A. Lagrange,
A. Saget, M. Bombled, P. Méchighel, M. Ay a di, M. Mu-
leris, A. de Reynies, M. Svrcek, J. F. Fléjou, J. C. Florent,
F. Mahuteau-Betzer, A. M. Faussat and A. Duval, “Ex-
tensive Characterization of Sphere Models Established
From Colorectal Cancer Cell Lines,” Cellular and Mole-
cular Life Sciences, 2012, in Press .
[11] M. Stevenson, W. Mostertz, C. Acharya, W. Kim, K.
Walters, W. Barry, K. Higgins, S. A. Tuchman, J. Craw-
ford, G. Vlahovic, N. Ready, M. Onaitis and A. Pott i,
“Characterizing the Clinical Relevance of an Embryonic
Stem Cell Phenotype in Lung Adenocarcinoma,” Clinical
Cancer Research, Vol. 15, 2009, pp. 7553-7561.
http://dx.doi.org/10.1158/1078-0432.CCR-09-1939
[12] E. Markert, A. J. Levine and A. Vazquez, “Proliferation
and Tissue Remodeling in Cancer: The Hallmarks Revi-
sited,” Cell Death & Disease, Vol. 3, 2012, p. 3397.
http://dx.doi.org/10.1038/cddis.2012.140
[13] N. Fankhauser, I. Cima, P. Wild and W. Krek, “Identifi-
cation of a Gene Expression Signature Common to Dis-
tinct Cancer Pathways,” Cancer Information, Vol. 11,
2012, pp. 139-146. http://dx.doi.org/10.4137/CIN.S9542
[14] M. Daves, S. G. Hilsenbeck, C. C. Lau and T. K. Man,
“Meta-Analysis of Multiple Microarray Datasets Reveals
a Common Gene Signature of Metastasis in Solid Tu-
mors,” BMC Med Genomics, Vol. 4, 2011, p. 56.
http://dx.doi.org/10.1186/1755-8794-4-56
[15] S. De and F. Michor, “DNA Secondary Structures and
Epigenetic Determinants of Cancer Genome Evolution,”
Nature Structural & Molecular Biology, Vol. 18, 2011,
pp. 950-955. http://dx.doi.org/10.1038/nsmb.2089
[16] F. Buffa, A. L. Harris, C. M. West and C. J. Miller,
“Large Meta-Analysis of Multiple Cancers Reveals a
Common, Compact and Highly Prognostic Hypoxia Me-
tagene,” British Journal of Cancer, Vol. 102, 2010, pp.
428-435. http://dx.doi.org/10.1038/sj.bjc.6605450
[17] N. Slavov and K. A. Da wson, “Correlation Signature of
the Macroscopic States of the Gene Regulatory Network
in Cancer,” Proceedings of the National Academy of
Sciences, Vol. 106, 2009, pp. 4079-4084.
http://dx.doi.org/10.1073/pnas.0810803106
[18] I. Wang, B. Zhang, X. Yang, J. Zhu, S. Stepaniants, C.
Zhang, Q. Meng, M. Peters, Y. He, C. Ni, D. S li petz, M.
A. Crackower, H. Houshyar, C. M. Tan, E.
Asante-Appiah, G. O’Neill, M. J. Luo, R. Thieringer, J.
Yuan, C. S. Chiu, P. Y. Lum, J. Lamb, Y. Boie, H. A.
Wilkinson, E. E. Schadt, H. Dai and C. Roberts, “Systems
Analysis of Eleven Rodent Disease Models Reveals an
Inflammatome Signature and Key Drivers,” Molecular
Systems Biology, Vol. 8, 2012, p. 594.
http://dx.doi.org/10.1038/msb.2012.24
[19] S. Michiels, S. Koscielny and C. Hill, “Prediction of can-
cer Outcome with Microarrays: A Multiple Random Va-
lidation Strategy,” Lancet, Vol. 365, 2005, pp. 488-492,
2005. http://dx.doi.org/10.1016/S0140-6736(05)17866-0
[20] E. Segal, N. Fr iedm an, D. Kol ler and A. Regev, “A Mod-
ule Map Showing Conditional Activity of Expression
Modules in Cancer,” Nature Genetics, Vol. 36, 2004, pp.